Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2025-12-24 @ 5:46 PM
NCT ID:
NCT02428868
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing hip fracture surgery within 72 h after trauma.
Exclusion Criteria:
* Vascular events within the last 2 months such as cerebrovascular accident (CVA), Myocardial infarction (MI), Venous Thromboembolism (VTE) and/or recurrent VTE or arterial thrombosis.
* Patients receiving anticoagulation therapy with warfarin or clopidogrel.
* History of seizures.
* Multiple fractures.
* Transfusion received during admission, prior to surgery (Hb\< 8g/dl).
* Creatinine clearance less than 30 mL/min
* Known history of Factor V Leiden, protein C/S deficiency, prothrombin gene mutation, anti-thrombin deficiency, anti-phospholipid antibody syndrome, lupus anticoagulant
* Coronary stent placement within the previous 6 months
* Disseminated intravascular coagulation
* Subarachnoid hemorrhage
* Allergy for tranexamic acid
* Hypersensitivity to Iron sucrose or any component of the formulation
* Clinical signs of acute thromboembolic event
* Malignancy
* Body weight \> 100kg
* Advanced Dementia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT02428868
Study Brief:
Protocol Section:
NCT02428868